Investor News

Metals and Mining: Outlook to improve strongly over 2 years
Kotak Institutional Equities | April 17, 2018 2:33 AM
There are not many large aluminum projects to be commissioned outside China over the next 2-3 years.
Strides Shasun rating: ICICI Securities says ‘Buy’; API demerger is value accretive
ICICI Securities | April 17, 2018 2:33 AM
Strides’ API business (15.2% of FY17 sales) would demerge into a separate listed entity, Solara Active Pharma Sciences Ltd (Solara), which will also have human API business of Sequent Scientific.
Why availability of coal at plants has been hit, IIFL explains
IIFL | April 16, 2018 3:34 AM
Importantly, the number of plants with critical-level coal stock has zoomed to 28 as of Mar-2018, with distant plants in western and northern India witnessing greater shortage.
Pharma Sector: Growth in ANDA filings a worry, says Credit Suisse
Credit Suisse | April 16, 2018 3:23 AM
FDA’s highest approvals last year were 850 but these were still lower than filing trend in any of the past five years.
Finolex Cables Rating ‘Buy’: Edelweiss says reasonable growth lies ahead
Edelweiss | April 16, 2018 3:23 AM
Notwithstanding the real estate slow-down, we expect 15/20% earnings/OCF growth over FY17-20 on strong growth in non-housing segments.
Banks with corporate focus likely to see muted Q4
Edelweiss | April 14, 2018 3:08 AM
As the VUCA phase will weigh on valuations of corporate-focused banks, we cut valuation multiple across corporate lenders by 10-20% and, consequently, revise down TPs in similar range. Prefer HDFC Bank and Yes Bank.
Softer refining may prove a drag in final quarter
Edelweiss | April 14, 2018 2:03 AM
As the VUCA phase will weigh on valuations of corporate-focused banks, we cut valuation multiple across corporate lenders by 10-20% and, consequently, revise down TPs in similar range. Prefer HDFC Bank and Yes Bank.
Matrimony.com rating: Buy; multiple factors boost growth prospects
ICICI Securities | April 14, 2018 1:46 AM
Initiated coverage with ‘Buy’ and TP of Rs 1,030, implying upside of 36% over CMP
ICICI Bank: Jefferies rates ‘buy’, says limited downside to stock from present levels
Jefferies | April 9, 2018 12:42 AM
ICICI Bank faces allegations of malpractice & conflict of interest involving the CEO. Media reports suggest a preliminary inquiry has been filed; overhang to continue until a speedy investigation & closure is reached.
Grasim Industries on a strong growth trajectory, Kotak Institutional Equities rates its ‘add’
Kotak Institutional Equities | April 9, 2018 12:27 AM
Grasim expects both legs of its standalone operations — vsf and chemicals — to see strong volume growth led by improved underlying demand and expanded capacities.
Zomato’s financials for FY18 encouraging, Morgan Stanley rates it ‘overweight’
Morgan Stanley | April 9, 2018 12:12 AM
Zomato released its key financials and metrics for FY18; we find these encouraging and believe that if momentum continues, the company could be well on course to achieving or beating our estimates.
Fortis Healthcare rating: Merger decision fails to enthuse the market
Nomura | April 7, 2018 12:08 AM
Fortis Healthcare announced merger plans with Manipal Hospitals. The combined entity will have an extensive pan-India presence and will emerge as the largest hospital chain in India in terms of revenues.
SpiceJet rating: Prospects of growth are robust
Edelweiss | April 7, 2018 12:08 AM
Soaring crude price notwithstanding, the company has maintained healthy earnings momentum as yields rose 7% YTD and traffic surged a robust 22%.
Auto and auto parts: March was strong across segments
Jefferies | April 7, 2018 12:08 AM
Auto sales remained strong with double-digit y-o-y growth across all segments in March. Within two-wheelers, TVS, Eicher and Hero all delivered strong growth with Bajaj being the only exception.
Outperformance is likely to continue
ICICI Securities | April 3, 2018 1:46 AM
Modest acceleration in FY19 and benign valuations are positives; cross currency to help reported revenues in Q4.
Kotak Institutional Equities rates Maruti Suzuki as ‘add’, says recent launches to keep momentum going
Kotak Institutional Equities | April 2, 2018 2:30 AM
Weak launch pipeline for competitors in next two years likely to work in company’s favour; FY18e EPS down 3% even as TP is revised to Rs 10,000 from Rs 10,500.
Marico rating ‘buy’: Edelweiss says prospects bright for company
Edelweiss | April 2, 2018 2:24 AM
Domestic growth to be steered by several catalysts; margin pressures are likely to ebb from H2FY19; ‘Buy’ retained with TP at Rs 373
Oil and Gas: Goldman Sachs says it’s age of restraint for investment; here’s why
Goldman Sachs | April 2, 2018 2:20 AM
Of the three investment cycle phases, Big Oils do best during Restraint while Oil Services and E&Ps fare well in Expansion phase
Consumer Finance: There’s strong opportunity for growth
Jefferies | March 31, 2018 3:50 AM
Consumer finance offers a large growth opportunity and while competition is intensifying in this segment, we believe only a few focused firms will be able to scale up given strong entry barriers, high opex intensity and long gestation period required to achieve critical mass and break even.
NBCC Rating hold: Monetisation of real estate will be key
Edelweiss | March 31, 2018 3:43 AM
NBCC management, during our recent interaction, reiterated its focus on execution of its Rs 800 bn order book (13x TTM revenue). The company has tendered out Rs 100 bn projects in the past six months and expects to maintain similar run rate going ahead.
Sun Pharmaceutical Industries Rating buy: ILUMYA’s approval a positive development
ICICI Securities | March 31, 2018 3:38 AM
Strong earnings growth likely from FY19; recent correction has made valuations attractive; upgraded to ‘Buy’.
Consumer Diary: Respite from input costs
Jefferies | March 27, 2018 3:36 AM
The overall RM basket has seen some cool-off with 2% MoM dip in February led by non food-RMs that dipped 3% MoM while food RMs dipped 1% MoM.
DXC and direct channel segments to grow faster; Mphasis gives ‘hold’ rating
ICICI Securities | March 27, 2018 3:31 AM
Given strong near-term momentum in deal intake, revenue growth and margin expansion, we upgrade Mphasis to Hold from Reduce.
Kotak Instituional Equities rates SBI ‘buy’, says subsidiaries are in good health
Kotak Institutional Equities | March 26, 2018 3:58 AM
While most of these businesses are strong on growth and/or profitability, the key concern is on the parent where the scope for valuation expansion is the highest.
JM Financial rates Galaxy Surfactants ‘buy’, says prospects of growth bright
JM Financials | March 26, 2018 3:49 AM
The Indian surfactants market is estimated to post a CAGR of 6% over FY15-24 and oleochemical-based surfactants could continue to gain market share. Galaxy is well-positioned to take advantage of this.
Why 2018 will be a challenging year for pharmaceuticals
Goldman Sachs | March 26, 2018 3:34 AM
Management teams were generally optimistic on the outlook for domestic Indian markets, with sales growth expected to be in the low double digits, rebounding from GST led disruption.
Goa Form483 is not a serious event
HSBC | March 24, 2018 3:21 AM
Cipla the preferred pick in challenging environment, on a comfortable India and EM base and strong US growth outlook

Budget 2018

Horoscope: By Peter Vidal

Today ( 23 Apr )This Week ( 22 Apr - 28 Apr )

SAGITTARIUS Your creative energy should now be at a peak, but not perhaps because the stars are all on your side. On the contrary, challenging romantic stars remind us of the cliché that all great art stems from… read more

Investor News

latest News

Industry Sectors

FROM THE PRINT

MORE